Abstract:484 Objectives: The Sphingosine-1-phosphate receptor 1 (S1PR1) plays an important role in immune-mediated diseases, such as multiple sclerosis (MS), colitis, influenza, rheumatoid arthritis, inflammatory bowel disease, and atherosclerosis. A suitable S1PR1 PET radiotracer will be very efficient for investigating the changes of S1PR1 in vivo for relative diseases. Based on our previous effort for the development of S1PR1 specific compounds, we recently have synthesized more than 50 new compounds, among which several compounds exhibited high S1PR1 binding potency. One of the most potent S1PR1 compounds was further radiosynthesized with F-18 for in vivo evaluation in rodents and nonhuman primates, to explore its potential to be a suitable S1PR1 PET radiotracer. Methods: A library of fluorine-containing S1PR1 specific compounds were synthesized and screened the in vitro binding potency assay. Using radioactive competitively radioactive assay in which different concentrations of each compound was used to compete with [32P]S1P binding with S1P receptor cell membrane. The precursor for F-18 labeling was also synthesized, and F-18 labeling radiosynthesis was carried out by employing a two-step one-pot procedure, incorporating the F-18 isotope and removal of the protection group. The final product was purified by reverse phase semi-preparative HPLC. The biodistribution study was conducted in adult male SD rats to determine the in vivo tracer distribution. Animals were euthanized at 5, 30, 60 min, and 120 min post injection of [18F]TZ67138. Tissues of interest were collected, weighed, and counted on an automated gamma counter. Uptake of radioactivity was calculated as percentage injected dose per gram (%I.D./g). Dynamic microPET study was performed on a male cynomolgus monkey (~10 kg) using a Focus 220 MicroPET scanner. Results: Five of the library ligands possessed good binding potency, with IC50 95%), as well as high specific activity (> 1.0 Ci/µmol, decay corrected to EOS). The biodistribution study in rats revealed that [18F]TZ67138had a rat brain uptake (%ID/gram) of 0.41 at 5 min, 0.21 at 30 min and 0.16 at 60 min. Similarly, the dynamic microPET scan of nonhuman primates showed that this tracer has good washout kinetics from the brain. The biodistribution study in rats indicated that [18F]TZ67138had good brain uptake (%ID/gram) up to 0.41 at 5 min. No defluroation was observed as the bone uptake was not increased from 5 to 120 min. Nonhuman primate microPET also demonstrated its ability to penetrate into the brain, with the mean SUV value of ~1.2. Conclusions: A series of new S1PR1 specific compounds were designed and synthesized. The in vitro binding affinity assay identified five of these compounds exhibited high binding potency towards S1PR1 (IC50

Design, Synthesis, and in Vitro Bioactivity Evaluation of Fluorine-Containing Analogues for Sphingosine-1-phosphate 2 Receptor.

Design, Synthesis, And Sar Studies Of Heteroarylpyrimidines And Heteroaryltriazines As Cb2r Ligands

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

Design, synthesis, and in vitro evaluation of new S1PR1 compounds and in vivo studies of an F-18 labeled radiotracer in rodents and monkeys

Design, synthesis, and biological evaluation of multiple F-18 S1PR1 radiotracers in rodent and nonhuman primate

Synthesis and in vitro characterization of novel fluorinated derivatives of the translocator protein 18 kDa ligand CfO-DPA-714

Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising σ1 receptor imaging agent.

Syntheses of Differentially Fluorinated Triazole-Based 1-Deoxysphingosine Analogues en route to SphK Inhibitors

Discovery of Novel 1,2,4-Thiadiazole Derivatives As Potent, Orally Active Agonists of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P(1)).

Synthesis and Biological Evaluation of 18F Labeled Fluoro-Oligo-ethoxylated 4-Benzylpiperazine Derivatives for Sigma-1 Receptor Imaging

Synthesis and Evaluation of New 1-Oxa-8-azaspiro[4.5]decane Derivatives As Candidate Radioligands for Sigma-1 Receptors

Structure−Activity Relationships of Fluorinated Lysophosphatidic Acid Analogues

Identification of benzoxazole analogs as novel, S1P3 sparing S1P1 agonists

Design, synthesis, and biological evaluation of novel pyrrolidinone small-molecule Formyl peptide receptor 2 agonists

Design, Synthesis and Biological Evaluation of a Series of Novel 2-Benzamide-4-(6-oxy-n-methyl-1-naphthamide)-pyridine Derivatives As Potent Fibroblast Growth Factor Receptor (FGFR) Inhibitors

Discovery of Thiadiazole Amides As Potent, S1p(3)-Sparing Agonists of Sphingosine-1-Phosphate 1 (s1p(1)) Receptor

Synthesis and in Vitro Evaluation of New Diphenyl Ether Derivatives As Serotonin Transporter Ligands

Optimization of 1H-Indazol-3-amine Derivatives As Potent Fibroblast Growth Factor Receptor Inhibitors.

Synthesis and Biological Evaluation of 9-Fluorenone Derivatives for SPECT Imaging of Α7-Nicotinic Acetylcholine Receptor

Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer

Design and Synthesis of Novel Aryloxyalkyl-Arylpiperazine Derivatives As Alpha(1a)-Adrenoceptor Antagonists